oxysporidinone and Neoplasms

oxysporidinone has been researched along with Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for oxysporidinone and Neoplasms

Article	Year
Chemical constituents from endophytic fungus Fusarium oxysporum. Fitoterapia, 2011, Volume: 82, Issue:5 A new oxysporidinone analogue (1) and a new 3-hydroxyl-2-piperidinone derivative (2), along with the known compounds (-)-4,6'-anhydrooxysporidinone (3), (+)-fusarinolic acid (4), gibepyrone D (5), beauvercin (6),cerevisterol (7), fusaruside (8), and (2S,2'R,3R,3'E,4E,8E)-1-O-D-glucopyranosyl-2-N-(2'-hydroxy-3'-octadecenoyl)-3-hydroxy-9-methyl-4,8-sphingadienine (9) were isolated from Fusarium oxysporum. Compounds 1-9 were evaluated for cytotoxicity using the MTT method against cancer cell lines, PC-3, PANC-1, and A549. Beauvericin showed cytotoxicity against PC-3, PANC-1, and A549 with IC(50) value of 49.5 ± 3.8, 47.2 ± 2.9, and 10.4 ± 1.6μM, respectively. Beauvericin also exhibited anti-bacterial activity towards methicillin-resistant Staphylococcus aureus (MIC=3.125 μg/mL) and Bacillus subtilis (MIC=3.125 μg/mL). Topics: Anti-Bacterial Agents; Antineoplastic Agents; Biological Products; Cell Line, Tumor; Fusarium; Humans; Methicillin-Resistant Staphylococcus aureus; Neoplasms; Phytotherapy; Piperidones; Pyridones	2011

Article

Year

Chemical constituents from endophytic fungus Fusarium oxysporum.

Fitoterapia, 2011, Volume: 82, Issue:5

A new oxysporidinone analogue (1) and a new 3-hydroxyl-2-piperidinone derivative (2), along with the known compounds (-)-4,6'-anhydrooxysporidinone (3), (+)-fusarinolic acid (4), gibepyrone D (5), beauvercin (6),cerevisterol (7), fusaruside (8), and (2S,2'R,3R,3'E,4E,8E)-1-O-D-glucopyranosyl-2-N-(2'-hydroxy-3'-octadecenoyl)-3-hydroxy-9-methyl-4,8-sphingadienine (9) were isolated from Fusarium oxysporum. Compounds 1-9 were evaluated for cytotoxicity using the MTT method against cancer cell lines, PC-3, PANC-1, and A549. Beauvericin showed cytotoxicity against PC-3, PANC-1, and A549 with IC(50) value of 49.5 ± 3.8, 47.2 ± 2.9, and 10.4 ± 1.6μM, respectively. Beauvericin also exhibited anti-bacterial activity towards methicillin-resistant Staphylococcus aureus (MIC=3.125 μg/mL) and Bacillus subtilis (MIC=3.125 μg/mL).

Topics: Anti-Bacterial Agents; Antineoplastic Agents; Biological Products; Cell Line, Tumor; Fusarium; Humans; Methicillin-Resistant Staphylococcus aureus; Neoplasms; Phytotherapy; Piperidones; Pyridones

2011